Microsatellite Instability-High Solid Malignant Tumor
Also known as: Microsatellite Instability-High Solid Malignant Tumour / MSI-H Solid Malignant Tumor / Microsatellite instability-high solid malignant tumor (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17508 | Hafnium oxide | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB08885 | Aflibercept | 1 / 2 | Recruiting | 1 |
| DB00062 | Albumin human | 1 / 2 | Recruiting | 1 |
| DB00112 | Bevacizumab | 1 / 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 1 / 2 | Recruiting | 1 |
| DB00544 | Fluorouracil | 1 / 2 | Recruiting | 1 |
| DB14865 | Human interleukin-2 | 1 / 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 1 / 2 | Recruiting | 1 |
| DB00762 | Irinotecan | 1 / 2 | Recruiting | 1 |
| DB00650 | Leucovorin | 1 / 2 | Recruiting | 1 |
| DB17100 | NEO-212 | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 2 |
| DB08896 | Regorafenib | 1 / 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB00331 | Metformin | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB00412 | Rosiglitazone | 2 | Recruiting | 1 |
| DB17451 | Serplulimab | 2 | Recruiting | 1 |